Phase I and pharmacokinetic study of mitomycin C and celecoxib as potential modulators of tumor resistance to irinotecan in patients with solid malignancies.
about
Is there still a role for mitomycin-based combination chemotherapy in treating patients with nonsmall cell lung cancer? A single institution experience.A phase I dose escalation study of a pharmacobiologically based scheduling of capecitabine and mitomycin C in patients with gastrointestinal malignanciesPhase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinomaA novel LMP1 antibody synergizes with mitomycin C to inhibit nasopharyngeal carcinoma growth in vivo through inducing apoptosis and downregulating vascular endothelial growth factorIndividualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics.
P2860
Phase I and pharmacokinetic study of mitomycin C and celecoxib as potential modulators of tumor resistance to irinotecan in patients with solid malignancies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Phase I and pharmacokinetic st ...... ients with solid malignancies.
@en
Phase I and pharmacokinetic st ...... ients with solid malignancies.
@nl
type
label
Phase I and pharmacokinetic st ...... ients with solid malignancies.
@en
Phase I and pharmacokinetic st ...... ients with solid malignancies.
@nl
prefLabel
Phase I and pharmacokinetic st ...... ients with solid malignancies.
@en
Phase I and pharmacokinetic st ...... ients with solid malignancies.
@nl
P2093
P2860
P1476
Phase I and pharmacokinetic st ...... ients with solid malignancies.
@en
P2093
G Otterson
J M Kolesar
L J Schaaf
M A Villalona-Calero
R Drengler
P2860
P2888
P304
P356
10.1007/S00280-008-0826-3
P577
2008-09-16T00:00:00Z